|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Gross profit (loss) | ||||
| Operating expenses: | ||||
| Sales and marketing | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| PPP loan forgiveness | ||||
| Interest expense | ||||
| Gain (Loss) on settlement of debt | ||||
| Loss on exchange of debt | ||||
| Gain (Loss) on issuance of warrants | ||||
| Gain on extinguishment of debt | ||||
| Changes in fair value of warrant and derivative liabilities | ||||
| Loss on issuance of warrants | ||||
| Penalties and settlements | ||||
| Interest income | ||||
| Other, net | ||||
| Total other expense | ||||
| Loss before income taxes | ||||
| Income tax provision | ||||
| Net loss | ||||
| Dividends on preferred stock | ||||
| Net loss allocable to common stockholders | ||||
| Net loss per share allocable to common stockholders, basic | ||||
| Net loss per share allocable to common stockholders, diluted | ||||
| Weighted average shares of common stock outstanding, basic | ||||
| Weighted average shares of common stock outstanding, diluted | ||||
Loading...
